Univest
Univest
  • Markets

Nifty Healthcare Prediction for Tomorrow, 22 July 2026: Healthcare Stocks Track Pharma’s Continued 0.34 Percent Gain

  • July 21, 2026
  • Posted by: Ankit Jaiswal
  • Category: News
No Comments
Nifty Healthcare Prediction for Tomorrow, 22 July 2026

Nifty Healthcare prediction for tomorrow 22 July 2026: healthcare stocks tracked Nifty Pharma’s continued 0.34 percent Tuesday gain to 26,092.85, a second straight positive session.

Nifty healthcare prediction for tomorrow: Healthcare stocks continued tracking a steady Tuesday gain in the closely related Nifty Pharma index, which closed 0.34 percent higher at 26,092.85, a second consecutive positive session that builds on Monday’s own sharp 1.40 percent rebound during the banking-earnings-driven selloff. This nifty healthcare prediction for tomorrow is built on Friday, 10 July 2026’s closing data, the last completed session before markets reopen on Monday, 13 July 2026.

Kunal Singla, Associate Director at Univest, notes that the Nifty Healthcare prediction for tomorrow reflects a sector consolidating its recent gains rather than reversing them, with Tuesday’s more modest pace, after Monday’s own sharper move, suggesting the defensive rotation has stabilised into a steadier, more sustainable pattern.

Click Here – Get Free Investment Predictions

Table of Contents

Toggle
  • Market Recap Behind the Nifty healthcare prediction for tomorrow
  • Nifty healthcare prediction for tomorrow: Trend and Key Levels
  • Global Cues for Nifty Healthcare Tomorrow
  • Key Triggers in the Nifty healthcare prediction for tomorrow
  • Related Sectors to Watch
  • Risks to the Nifty healthcare prediction for tomorrow
  • Conclusion
  • FAQs on the Nifty healthcare prediction for tomorrow
    • What is the Nifty Healthcare prediction for tomorrow, 22 July 2026?
    • Which analyst gave the Nifty Healthcare prediction for tomorrow?
    • Is healthcare’s rally continuing at the same pace as Monday?
    • Why has healthcare stayed strong through this volatile week?

Market Recap Behind the Nifty healthcare prediction for tomorrow

Nifty Pharma, the closest tracked proxy for the healthcare sector, opened at 26,007.20, touched a high of 26,108.70 and a low of 25,878.20 before closing at 26,092.85, up a steady 0.34 percent. This marks a second consecutive positive session, extending Monday’s sharp defensive-rotation-driven rebound at a calmer, more sustainable pace.

Nifty healthcare prediction for tomorrow: Trend and Key Levels

Trend: Bullish Above 25,880

Kunal Singla notes Nifty Pharma’s own 25,880 support and 26,110 resistance zone serves as the closest available reference for the Nifty Healthcare prediction for tomorrow, given the substantial constituent overlap between the two indices.

Global Cues for Nifty Healthcare Tomorrow

Yemen’s Iran-aligned Houthis announced a naval blockade on Saudi Arabia on Monday, opening a fresh front in the regional conflict and pushing Brent crude back toward 90 dollars a barrel. Indian equities traded cautiously lower through Tuesday’s session, with the Nifty MidCap and SmallCap indices outperforming the headline benchmarks. HDFC Bank extended its Monday crash into a second straight session, while Nifty Cement led sectoral gains. Healthcare and pharma stocks remain largely insulated from these geopolitical and earnings-driven cues, which continues to support the sector’s relative stability through this genuinely volatile week.

Key Triggers in the Nifty healthcare prediction for tomorrow

These triggers dominate the outlook heading into Monday, 13 July 2026:

  • Continued sector consolidation: A third straight positive session would further confirm the defensive rotation has staying power.
  • US generic pricing developments: Any regulatory or pricing news from the US market remains an added sector-specific catalyst.
  • HDFC Bank extended its post-results crash into a second straight session on Tuesday, falling a further 2.08 percent to Rs 761.45, among Nifty 50’s biggest losers again.

Talk to a SEBI Registered Investment Advisor Before Your Next Trade

Related Sectors to Watch

Healthcare sentiment is best tracked alongside the closely related pharma index.

Nifty Pharma: Nifty Pharma closed at 26,092.85, up 0.34 percent, the closest available proxy.

Nifty FMCG: Nifty FMCG eased slightly Tuesday, a divergence from healthcare’s own continued strength among defensives.

Risks to the Nifty healthcare prediction for tomorrow

These factors can invalidate this outlook:

  • Rotation reversal: If broader market sentiment stabilises further, defensive sectors like healthcare could see some profit booking.
  • US regulatory news: Any adverse FDA or pricing decision would be a sector-specific negative.
  • Extended consolidation weakening: If Wednesday sees a decline, it could suggest the recent rally is genuinely fading.

Download the Univest iOS App or Univest Android App to get daily sector research and SEBI registered analyst views on Univest.

Conclusion

The Nifty Healthcare prediction for tomorrow, 22 July 2026, is bullish above 25,880, after the sector posted a second straight steady gain, consolidating Monday’s sharp defensive-rotation rebound. Kunal Singla flags Nifty Pharma’s own levels as the closest reference for the Nifty Healthcare prediction for tomorrow heading into Wednesday.

Disclaimer: Data and figures in this article are sourced from publicly available information. These may or may not be accurate. Please verify all data with the official NSE (nseindia.com) and BSE (bseindia.com) websites before making any investment decision. Investments in securities are subject to market risk. This content is for educational purposes only and is not investment advice by Univest (SEBI RA INH000013776).

FAQs on the Nifty healthcare prediction for tomorrow

What is the Nifty Healthcare prediction for tomorrow, 22 July 2026?

Ans. The Nifty Healthcare prediction for tomorrow, 22 July 2026, is bullish above 25,880. Healthcare stocks tracked Nifty Pharma’s continued 0.34 percent Tuesday gain, a second straight positive session.

Which analyst gave the Nifty Healthcare prediction for tomorrow?

Ans. Kunal Singla, Associate Director at Univest, has shared the Nifty Healthcare prediction for tomorrow, tracking it closely against Nifty Pharma given significant constituent overlap.

Is healthcare’s rally continuing at the same pace as Monday?

Ans. Not quite; the Nifty Healthcare prediction for tomorrow notes Tuesday’s 0.34 percent gain was notably calmer than Monday’s sharp 1.40 percent rebound, a pattern suggesting the sector is consolidating its recent gains at a steadier, more sustainable pace.

Why has healthcare stayed strong through this volatile week?

Ans. Healthcare and pharma have remained largely insulated from the geopolitical and earnings-driven cues moving other sectors this week, which the Nifty Healthcare prediction for tomorrow flags as the reason behind the sector’s continued relative stability.



News
Author: Ankit Jaiswal
Ankit Jaiswal is the Senior Research Analyst at Univest, leading the platform's in-house equity research desk and serving as the editorial reviewer for all research and blog content published at univest.in. With 11+ years of experience in Indian equity markets, he oversees stock recommendations, earnings analysis, sector coverage, and ensures every published article meets SEBI Research Analyst Regulations. He holds a Bachelor of Commerce (B.Com) from St. Xavier's College, Kolkata — one of India's most prestigious commerce institutions — and has cleared CMT Level 2 from the CMT Association, a globally recognised certification in technical analysis and market research. His research methodology combines fundamental analysis (earnings quality, balance sheet strength, management commentary) with advanced technical analysis (chart patterns, momentum indicators, market structure) — giving Univest's retail investors a dual-lens approach that most Indian research platforms lack. Ankit is among the most comprehensively certified analysts in Indian financial media, holding five NISM certifications: Series-XV (Research Analyst), Series-VIII (Equity Derivatives), Series-VII (SORM), Series-VI (Depository Operations), and Series-V-A (Mutual Fund Distributors). At Univest — India's SEBI-registered research and advisory platform — Ankit's responsibilities include leading the research team, finalising stock recommendations published across Pro Lite, Pro Super, and Pro Gold advisory services, and maintaining editorial oversight of all YMYL financial content published on the blog.

Leave a Reply Cancel reply